Minimally Invasive Surgery Market, By Device Type (Surgical Devices (Ablation Devices, Electrosurgical Devices, and Medical Robotic Systems), Monitoring & Visualization Devices, and Endoscopy Devices), By Surgery (Orthopedic Surgery, Cosmetic Surgery, Bre

Minimally Invasive Surgery Market, By Device Type (Surgical Devices (Ablation Devices, Electrosurgical Devices, and Medical Robotic Systems), Monitoring & Visualization Devices, and Endoscopy Devices), By Surgery (Orthopedic Surgery, Cosmetic Surgery, Breast Surgery, Vascular Surgery, Thoracic Surgery, Gynecological Surgery, Bariatric Surgery, Cardiac Surgery, Gastrointestinal Surgery, and Urological Surgery) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Minimally invasive surgery are performed using smaller incisions made in the patient’s body for surgical treatment of a disease or condition that causes less trauma to the patient, and provides faster recovery time. Minimally invasive surgery include robotic surgery and non-robotic minimally invasive surgery. In minimally invasive surgery, doctors uses a variety of techniques to operate with less damage to the body as compared to open surgery. In general, minimally invasive surgery is associated with less pain, a shorter hospital stay, and fewer complications. Laparoscopy surgery is done through one or more small incisions by using small tubes and tiny cameras, and surgical instruments was one of the first types of minimally invasive surgery. Another type of minimally invasive surgery is robotic surgery. It provides a magnified, 3D view of the surgical site, and helps the surgeon operate with precision, flexibility, and control.

Market Dynamics

Increasing adoption of organic growth strategies such as product launches by key market players to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in December 2022, Abbott, a global healthcare company, announced that it has launched its latest-generation transcatheter aortic valve implantation (TAVI) system named Navitor, and thus, making the minimally invasive device available for people in India with severe aortic stenosis who are at high or extreme surgical risk. With the Navitor valve, the company is advancing TAVI (also referred to as TAVR, or transcatheter aortic valve replacement) therapies with innovations including a unique design to prevent blood leaking around the valve. The Navitor TAVI system is the latest addition to the company's comprehensive structural heart transcatheter portfolio that offers physicians and patients less invasive options to treat heart diseases.

Key features of the study:

• This report provides in-depth analysis of the global minimally invasive surgery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global minimally invasive surgery market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, Integrated Endoscopy
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global minimally invasive surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minimally invasive surgery market

Detailed Segmentation:

• Global Minimally Invasive Surgery Market, By Device Type:
• Surgical Devices
• Ablation Devices
• Electrosurgical Devices
• Medical Robotic Systems
• Monitoring & Visualization Devices
• Endoscopy Devices
• Global Minimally Invasive Surgery Market, By Surgery:
• Orthopedic Surgery
• Cosmetic Surgery
• Breast Surgery
• Vascular Surgery
• Thoracic Surgery
• Gynecological Surgery
• Bariatric Surgery
• Cardiac Surgery
• Gastrointestinal Surgery
• Urological Surgery
• Global Minimally Invasive Surgery Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbott*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• ArthroCare Corporation
• Integer Holdings Corporation
• Zimmer Biomet
• DePuy Synthes, Inc.
• Conmed Corporation
• GE Healthcare
• Given Imaging Ltd.
• Intuitive Surgical, Inc.
• Medtronic, plc.
• NuVasive, Inc.
• Philips Healthcare
• InMode Ltd.
• Titan Medical Inc.
• Fractyl Inc.
• Biom’up SA
• Integrated Endoscopy

“*” marked represents similar segmentation in other categories in the respective section.